The method of administering platelet-rich fibrin is 100% safe, as it comes from the patient's own blood, unlike platelet-rich plasma a fine, three-dimensional structure. Platelet-rich fibrin is also obtained differently than plasma – the centrifugation speed is much lower than for platelet-rich plasma, which leads to its complete separation.
The procedure consists of 3 stages. The first stage is drawing blood from a vein in the crook of the elbow. The second stage is centrifuging it in a specialised centrifuge, similar to platelet-rich plasma. The result is obtaining a preparation with a cross-linked, three-dimensional fibrin fibre structure. The preparation contains an appropriate amount of blood platelets and growth factors. The final stage of the procedure is administering the platelet-rich fibrin to the patient, which is done by injection along wrinkle lines or directly into the subcutaneous tissue using the method Needle mesotherapy or using a cannula.
The procedure is not long and is 100%% safe for the patient, as there is no risk of an allergic reaction. Bruising or needle marks may occur after the procedure. 3 to 5 treatments are recommended at intervals of 3 to 4 weeks. After a series of treatments, it is recommended to have maintenance treatments at intervals of 3-6 months.
Platelet-rich fibrin – indications
It is mainly used for skin regeneration, making it a method for improving facial appearance, reducing wrinkles, enhancing the aesthetics of the eye area, or treating nasolabial folds. Platelet-rich fibrin can help improve the appearance of the skin on the neck, décolletage, and hands. It aids in treating hair loss or removing scars and stretch marks. Its wide range of applications has gained millions of supporters among patients of aesthetic medicine clinics worldwide.
Platelet-rich fibrin – contraindications
- blood diseases
- tumours
- skin inflammation
- Pregnancy and lactation
- Active herpes
- Anticoagulant treatment
- Taking aspirin
- uncontrolled diabetes
- Acute conditions of autoimmune diseases
